// App-Quantinova.ai

4067 : Myeloproliferative (MPN) Symptom Burden Response Thresholds: Assessment Of MPN-SAF TSS Quartiles As Potential Markers Of Symptom Response

Researchers

Presenter

  • Robyn M. Emanuel

Principal Investigators

  • Holly Lynn Geyer

  • Ana Kerguelen Fuentes

  • Heike L. Pahl

  • Frank Stegelmann

  • Konstanze Doehner

  • Thomas Lehmann

  • Karin Bonatz

  • Andreas Reiter

  • Francoise Boyer

  • Gabriel Etienne

  • Jean-Christophe Ianotto

  • Jean-Jacques Kiladjian

  • Dana Ranta

  • Lydia Roy

  • Jean-Yves Cahn

  • Claire N Harrison

  • Deepti H Radia

  • Pablo J. Muxi

  • Norman I Maldonado

  • Carlos Besses

  • Francisco Cervantes

  • Peter Johansson

  • Stephanie Slot

  • Tiziano Barbui

  • Giovanni Barosi

  • Alessandro M. Vannucchi

  • Francesco Passamonti

  • Bjorn Andreasson

  • Maria Ferrari

  • Martin Griesshammer

  • Alessandro Rambaldi

  • Jan Samuelsson

  • Gunnar Birgegard

  • Sonja Zweegman

  • Zhijian Xiao

  • Zefeng Xu

  • Yue Zhang

  • Xiujuan Sun

  • Junqing Xu

  • Peihong Zhang

  • Robert Peter Gale

  • Ayalew Tefferi

  • Peter te Boekhorst

  • Suzan Commandeur

  • Harry C Schouten

  • Federico Sackmann

  • Dolores Hernandez

Medical Centers

  • Hopital Saint-Louis and Universite Paris Diderot, Paris, France

  • Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Internal Medicine, Mayo Clinic, Scottsdale, AZ

  • Department of Hematology/Oncology, Goethe-University Hospital Frankfurt, Frankfurt Am Main, Germany

  • Division of Medical Oncology, Mayo Clinic, Rochester, MN

  • Hamatologie und Onkologie, Hamostaseologie und Palliativmedizin, Johannes Wesling Klinikum Minden, Minden, Germany

  • Department of Internal Medicine, Stockholm South Hospital, Stockholm, Sweden

  • Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom

  • Mayo Clinic, Scottsdale, AZ

  • School of Medicine, University of Puerto Rico, San Juan, PR

  • Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany

  • Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

  • Department of Pathology, Institute of Hematology, Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China

  • Dermatology Department, Hospital Clinic of Barcelona, Barcelona, Spain

  • Internal Medicine, NU Hospital Organization, Uddevalla, Sweden

  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China

  • GATLA, Grupo Argentino de Tratamiento de Leucemia Aguda, Buenos Aires, Argentina

  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China

  • Department of radiology, LUMC, Leiden, Netherlands

  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China

  • CHU de Poitiers et INSERM CIC 802, Poitiers University Hospital, Poitiers, France

  • Haematology, University Hospital, Basel, Switzerland

  • Department of Hematology, Nancy University Hospital, Vandoeuvre-Les-Nancy, France

  • Unidadde Hematologia, Hospital Britanico, Montevideo, Uruguay

  • Hematology Department, Grenoble University Hospital, Grenoble, France

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Department of Hematology and Oncology, University Hospital, Rostock, Germany

  • Department of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden

  • Institut Bergonie, CLCC Bordeaux, Bordeaux, France

  • Hospital Universitario La Paz, Madrid, Spain

  • Department of Medical Oncology, Maastricht University Medical Center, Maastricht, Netherlands

  • Department of Haematology,, University Hospital La Paz, Madrid, Spain

  • Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Department of Hematology, Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

  • Institute of Hematology and Blood Diseases Hospital, Tianjin, China

  • Urologische Klinik Universitatsmedizin Mannheim, Mannheim, Germany

  • Hospital del Mar, Hematology Department, Barcelona, Spain

  • Ospedali Riuniti di Bergamo, Bergamo, Italy

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

Locations

  • China

  • Argentina

  • Italy

  • Netherlands

  • Germany

  • Spain

  • United Kingdom

  • Switzerland

  • Uruguay

  • United States

  • France

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Essential thrombocythemia

  • Polycythemia vera

  • Myelofibrosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved